Saroja Pharma Industries India Limited — Others, 18-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Saroja Pharma Industries has affirmed its compliance for the quarter ended June 30, 2025, concerning investor shareholdings. Its Registrar and Share Transfer Agent confirmed that all required information regarding shares converted to or from electronic form (dematerialized/rematerialized) has been duly submitted to stock exchanges. This routine but important disclosure demonstrates the company's commitment to maintaining transparent and accurate records of its shares, ensuring proper oversight for all shareholders and contributing to market trust.